Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
76,818
Value
$12.9M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NBIX by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202676,818$12.9M<0.1%+8,431+12.3%AddedHolders
Q1 202668,387$9.01M<0.1%+15,121+28.4%AddedHolders
Q4 202553,266$7.55M<0.1%+20,800+64.1%AddedHolders
Q3 202532,466$4.56M<0.1%+18,221+127.9%AddedHolders
Q2 202514,245$1.79M<0.1%+3,422+31.6%AddedHolders
Q1 202510,823$1.20M<0.1%−8,661−44.5%ReducedHolders
Q4 202419,484$2.66M<0.1%+6,485+49.9%AddedHolders
Q3 202412,999$1.50M<0.1%+1,426+12.3%AddedHolders
Q2 202411,573$1.59M<0.1%+30+0.3%AddedHolders
Q1 202411,543$1.59M<0.1%+1,829+18.8%AddedHolders
Q4 20239,714$1.28M<0.1%+1,452+17.6%AddedHolders
Q3 20238,262$929.5K<0.1%+841+11.3%AddedHolders
Q2 20237,421$699.8K<0.1%−101−1.3%ReducedHolders
Q1 20237,522$761.4K<0.1%+708+10.4%AddedHolders
Q4 20226,814$813.9K<0.1%−492−6.7%ReducedHolders
Q3 20227,306$776.0K<0.1%+2,164+42.1%AddedHolders
Q2 20225,142$501.0K<0.1%+1,102+27.3%AddedHolders
Q1 20224,040$379.0K<0.1%−16−0.4%ReducedHolders
Q4 20214,056$345.0K<0.1%+128+3.3%AddedHolders
Q3 20213,928$377.0K<0.1%+278+7.6%AddedHolders
Q2 20213,650$355.0K<0.1%−261−6.7%ReducedHolders
Q1 20213,911$380.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.